Zydus Lifesciences Acquires 85.6% Stake in Amplitude Surgical

March 11, 2025

Zydus Lifesciences agreed to acquire an 85.6% controlling stake in French medtech company Amplitude Surgical for €6.25 per share (total consideration €256.8 million) and has completed the block acquisition. Zydus will file a mandatory simplified cash tender offer for the remaining shares at the same price with the aim of securing >90% of capital and implementing a squeeze-out and delisting; Amplitude Surgical is a Valence-based leader in lower-limb orthopaedic implants with ~429 employees and ~€111m revenue (FY Jun 2025).

Buyers
Zydus Lifesciences Limited
Targets
Amplitude Surgical
Sellers
PAI Partners, Amplitude Surgical management (including founder/CEO Olivier Jallabert), Two minority shareholders
Industry
Medical Devices
Location
Auvergne-Rhône-Alpes, France
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.